Alzheimer’s research in the United States is a massive, multi-billion-dollar ecosystem. It is led by a powerful and highly coordinated mix of federal government agencies, non-profit foundations, and elite academic medical centers.

Our bodies undergo many changes. One such change involves the accumulation of senescent cells. These are cells that have stopped dividing but don't die off as they should. They can linger in our tissues, releasing substances that promote inflammation and contribute to age-related diseases. This is where senolytic therapy comes into play.